Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Dante Rotili

53PUBLICATIONS

170CO-AUTHORS

Cheminformatics and quantitative structure-activity relationshipsHaematological tumoursMolecular targetsGene and molecular therapyLiquid biopsies

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (53)

Sort by Publication Date:

|May 05, 2026

Development of High-Affinity CHD1 Chromodomain Inhibitors.

|Apr 30, 2026

Development of Biphenyl-Substituted Uracil-Based Hydroxamic Acids (UBHAs) as Potent HDAC Inhibitors with Pro-Apoptotic Activity in Leukemia and Prostate Cancer Cells.

|Jan 28, 2026

A Combined SIRT5 Activation and SIRT3 Inhibition Prevents Breast Cancer Spheroids Growth by Reducing HIF-1α and Mitophagy.

Federica Barreca, Michele Aventaggiato, Mario Cristina

|Dec 31, 2025

Correction: Sennato et al. Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T <i>PTPN22</i> Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity. <i>Pharmaceutics</i> 2025, <i>17</i>, 710.

Simona Sennato, Giorgia Paldino, Cecilia Bombelli

|Nov 27, 2025

A Feasibility Study of Co-Established Patient-Derived Subcutaneous Xenograft and Organotypic Slice Cultures in Hormone-Naive Primary Prostate Cancer Preclinical Modeling: A Single-Institution Experience.

Valeria Pecci, Melissa Borsa, Aurora Aiello

|Nov 04, 2025

Sirtuin modulators: a review of patents from 2020 to 2024.

Emanuele Fabbrizi, Francesco Fiorentino, Antonello Mai

Pageof 9

Frequent Collaborators

41 joint publications

Antonello Mai

25 joint publications

Francesco Fiorentino

6 joint publications

Sergio Valente

5 joint publications

Lucia Altucci

4 joint publications

Rino Ragno

4 joint publications

Clemens Zwergel

3 joint publications

Matteo Antonio Russo

3 joint publications

Anna Maria Caccuri

3 joint publications

Luigi Sansone

3 joint publications

Marco Tafani

Frequent Collaborators

41 joint publications

Antonello Mai

25 joint publications

Francesco Fiorentino

6 joint publications

Sergio Valente

5 joint publications

Lucia Altucci

Top Related Videos

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on : Oct 26, 2015

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS

Published on : Aug 10, 2017

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on : Jan 18, 2017

See more related videos

Top Related Videos

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on : Oct 26, 2015

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS

Published on : Aug 10, 2017

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on : Jan 18, 2017

See more related videos